Cancer
News Category
Flow Cytometry Diagnostics Market Set to Reach USD 3.5 Billion by 2036 Driven by MRD Testing and Multiparametric Analysis
The flow cytometry diagnostics market is projected to grow from USD 1.5 billion in 2026 to USD 3.5 billion by 2036, driven by rising demand for hemato...
GeoVax Reports Second Quarter 2026 Financial Results and Advances GEO-MVA Towards Pivotal Immunobridging Study
GeoVax Labs reported a net loss of $4.4 million for Q2 2026 and provided updates on its lead programs, including preparation for a pivotal immunobridg...
Onco-Innovations Advances Lead Oncology Candidate ONC010 Toward Clinical Studies
Onco-Innovations Limited is progressing its lead oncology candidate ONC010, a PNKP inhibitor, by scaling up manufacturing, forming partnerships for dr...
Experimental Immunotherapy Shows Promise for Pediatric Brain Cancer
A study in Nature Medicine reveals that experimental immunotherapy could offer new hope for children with aggressive brain and spinal cord tumors, whi...
VERAXA Biotech Advances Bispecific ADC Program with OmniAb, Targeting Solid Tumors with Precision 'AND-Gate' Approach
VERAXA Biotech AG (NASDAQ: VRXA) has advanced its bispecific antibody-drug conjugate program VXA-222 after OmniAb completed discovery work, leveraging...
Onco-Innovations Integrates PNKP Inhibition, Nanoparticle Delivery, and AI to Tackle Cancer Drug Development Challenges
Onco-Innovations combines a novel PNKP inhibitor, nanoparticle delivery, and AI via its Inka Health subsidiary to address resistance, trial costs, and...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Drive BiTAC Platform Development
VERAXA Biotech names Christoph Erkel, Ph.D., as chief scientific officer to lead advancement of its BiTAC platform for solid tumor cancer therapies, s...
VERAXA Biotech Receives Positive Regulatory Feedback from Germany for BiTAC®-TCE Development
VERAXA Biotech has obtained Scientific Advice from Germany's Paul-Ehrlich-Institute supporting the development strategy for its lead BiTAC®-TCE progra...
Onco-Innovations Advances Precision Oncology with Lead Candidate ONC010
Onco-Innovations is developing ONC010, a biomarker-driven cancer therapy, aligning with the industry shift toward precision medicine.
Recent Outbreaks Expose Public Health System Gaps; At-Home Diagnostics Emerge as Key Tool
Recent U.S. outbreaks of measles, mpox, and HIV have exposed critical gaps in public health systems, highlighting the need for widely accessible point...
Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma announced a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for LP-184 therapy, advancing p...
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC Platform
VERAXA Biotech AG appointed Christoph Erkel, Ph.D., as chief scientific officer to lead the development of its proprietary BiTAC platform for cancer t...
iOrganBio Appoints Stem Cell Authority Lee L. Rubin, Ph.D. to Scientific Advisory Board
iOrganBio expands its Scientific Advisory Board with Lee L. Rubin, Ph.D., a leading stem cell biologist and Harvard professor, to advance its CellForg...
Quantum BioPharma Develops Dual Approach to Neurological Disorders, Targeting MS and Alcohol Effects
Quantum BioPharma (QNTM) is advancing treatments for multiple sclerosis with Lucid-MS and alcohol intoxication with unbuzzd, addressing significant un...
Oncotelic Therapeutics Publishes Preclinical Data Supporting Intravenous Cancer Therapy with Sapu003
Oncotelic Therapeutics announced publication of preclinical data for Sapu003, an intravenous everolimus formulation, supporting its Phase 1 trial in a...
Dietary Fat Balance Could Influence Immune System Function, Study Finds
A new study indicates that the ratio of polyunsaturated to monounsaturated fats in the diet may affect immune cell membrane composition and vulnerabil...
Kairos Pharma Collaborates With Bayer to Evaluate Combination Therapy for Advanced Prostate Cancer
Kairos Pharma has partnered with Bayer to test its antibody ENV-105 in combination with XOFIGO for metastatic castration-resistant prostate cancer, ai...
VERAXA Biotech Receives Positive Regulatory Feedback from Germany for BiTAC(R)-TCE Development
VERAXA Biotech AG announced that Germany's Paul-Ehrlich-Institute has provided Scientific Advice supporting the development strategy for its lead BiTA...
Greenwich LifeSciences Advances Phase 3 Trial for Breast Cancer Immunotherapy GLSI-100
Greenwich LifeSciences reports DSMB recommends continuation of Phase 3 FLAMINGO-01 trial for GLSI-100, with plans to expand enrollment to 2,000 patien...
Quantum BioPharma Targets Two Major Neurological Disorders with Novel Pipeline
Quantum BioPharma is developing Lucid-MS for multiple sclerosis and unbuzzd for alcohol intoxication, addressing significant unmet needs in neurologic...
WHO Study Finds No Evidence That Mobile Phones Cause Brain Cancer
A comprehensive World Health Organization review of 13 studies found no link between mobile phone use and brain cancer, offering reassurance to billio...
Michael Svestka, MD, FACS, Named a 2026 Castle Connolly Top Doctor
Dr. Michael Svestka, a general surgeon at Virginia Hernia & General Surgery, has been recognized as a 2026 Castle Connolly Top Doctor, an honor awarde...
Gut Microbiome Emerges as Key Player in Biliary Atresia, Review Finds
A new review in the World Journal of Pediatric Surgery reveals that gut microbiome imbalances in infants with biliary atresia are linked to worse outc...
World Brain Day: A time to (re)think what brain health really means
The Alzheimer's Association launches the (re)think your brain initiative to translate brain health research into practical habits, addressing the gap ...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech received Scientific Advice from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE cancer therapy program, providing clarity on develop...
VERAXA Biotech Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
VERAXA Biotech announced regulatory feedback from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE cancer therapy, advancing the program toward clin...
Cayenne Wellness Center to Debut 'Scar Stories' Art Exhibit Highlighting Sickle Cell Warriors' Experiences
Cayenne Wellness Center is launching 'Scar Stories: A Visual Testimony of Sickle Cell Warriors,' an art exhibit combining portraits and personal narra...
SS Innovations International to Feature SSi Mantra Surgical Robotic System at Society of Robotic Surgery Annual Meeting
SS Innovations International (NASDAQ: SSII) will showcase its SSi Mantra surgical robotic system at the 2026 Society of Robotic Surgery Annual Meeting...
Episode 1886 of No Agenda Dissects Cyclospora Outbreak, Senator Graham Autopsy, and Media Narratives
The podcast explores the multi-state cyclosporiasis outbreak, the FBI investigation into Senator Lindsey Graham's death, and media manipulation, urgin...
Gut Microbial Metabolites Linked to Improved Immunotherapy Response in Cancer Patients
A recent study identifies metabolites produced by gut bacteria that enhance cancer immunotherapy efficacy, offering a potential biomarker and therapeu...
SS Innovations to Highlight SSi Mantra Robotic System at Society of Robotic Surgery Annual Meeting
SS Innovations International will showcase its SSi Mantra surgical robotic system at the 2026 Society of Robotic Surgery Annual Meeting, including a l...
Wildfire Smoke Combined with Extreme Heat Poses Severe Cardiovascular Risks, American Heart Association Warns
The American Heart Association warns that the combination of wildfire smoke and extreme heat significantly increases the risk of heart attacks, cardia...
NeuroOne Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
NeuroOne Medical Technologies Corporation announced a collaboration with Mayo Clinic to evaluate a novel treatment approach for pediatric diffuse midl...
Birmingham OB/Gyn to Open Trussville Women's Health Center, Expanding Access to Comprehensive Care
Birmingham OB/Gyn announces the development of the Trussville Women's Health Center, a full-service regional hub that will bring expanded women's heal...
Dr. Jacqueline Youtsos Scholarship Now Accepting Applications for Aspiring Physicians
The Dr. Jacqueline Youtsos Scholarship for Medical Students is now accepting applications, offering a $1,000 award to students who demonstrate resilie...
Tits R Cool Launches Boldest Graphic Tees Yet, Blending Edgy Design with Breast Cancer Awareness
Tits R Cool releases a new collection of edgy graphic t-shirts for men and women, combining rebellious aesthetics with a philanthropic mission to supp...
Jett Foundation Launches $10.7M Capital Campaign for First-of-Its-Kind Duchenne Sanctuary
Jett Foundation's capital campaign to build Jett's Place, a barrier-free wellness and retreat center for the Duchenne muscular dystrophy community, ha...
Nuvectis Pharma Prices $100 Million Public Offering to Advance Pipeline Programs
Nuvectis Pharma announced the pricing of a $100 million public offering to fund the development of its NXP100, NXP200, and NXP900 programs, including ...
Kairos Pharma Reports Favorable Interim Phase 1 Safety Data for ENV-105 in EGFR-Mutated Lung Cancer
Kairos Pharma announced positive interim safety results from its Phase 1 trial of ENV-105 combined with osimertinib for advanced EGFR-mutated NSCLC, s...
Growing Evidence Links Respiratory Infections to Cardiovascular Disease, Expert Says
Professor Colin Russell highlights that respiratory infections are strongly linked to cardiovascular disease events, a connection that is often overlo...
VERAXA Biotech Partners With Ardigen to Advance AI-Driven Cancer Drug Development
VERAXA Biotech has partnered with Ardigen to integrate artificial intelligence into its BiTAC pipeline, aiming to improve tumor targeting and reduce t...
Aortic Dissection: A Silent Killer Claims Senator Lindsey Graham
An aortic dissection is a life-threatening tear in the aorta's inner layer, often fatal if untreated, and the sudden death of Senator Lindsey Graham h...
NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides has received National Ethics Committee approval in the DRC for a Phase II trial of its oral NV-387 gummies against the Bundibugyo ebolav...
Thyroid Hormone Shows Promise in Preventing Pediatric Brain Tumor Recurrence
Research indicates that adding the thyroid hormone triiodothyronine (T3) to standard chemotherapy could prevent recurrence of pediatric brain tumors, ...
Onco-Innovations Completes Analytical Reference Standard Program for ONC010, Advancing Toward Clinical Readiness
Onco-Innovations announced the completion of its analytical reference standard program for ONC010's active ingredient, strengthening its CMC framework...
Novel Feeder-Free TIL Expansion Platform Reduces IL-2 Dependence and Enhances Safety in Preclinical Study
A new feeder-free TIL expansion protocol using low-dose IL-2 and PD-1 blockade improves safety and efficacy, potentially making TIL therapy more acces...
New Framework Classifies Breast Cancer by Immune Cycle Steps, Paving Way for Personalized Immunotherapy
Researchers developed a classification system based on the cancer-immunity cycle that identifies three breast cancer subtypes with distinct immune def...
Microbiome emerges as key target in cancer therapy, new special issue reveals
A special issue of Cancer Biology & Medicine highlights the microbiome's active role in cancer development and treatment, advocating for integrated mi...